Toft Group Completes Executive Search for aTyr Pharma, Inc. (Nasdaq:LIFE) in San Diego, CA
Executive search firm Toft Group has placed Dr. Ari Gershman, DO as Senior Medical Director at aTyr Pharma, Inc. (Nasdaq:LIFE) in San Diego, CA. Previously Dr. Gershman served as the Executive Medical Director of Clinical Development at Xencor in San Diego, CA. He earned a DO degree from A.T. Still University of Health Sciences in Kirksville, MO.
About aTyr Pharma, Inc.
Headquartered in San Diego, CA, aTyr Pharma is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of Physiocrine biology, a newly discovered set of physiological modulators. The Company's lead candidate, Resolaris™, is a first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an immune component. The Company was founded by Professors Paul Schimmel, Ph.D., and Xiang-Lei Yang, Ph.D., two leading aminoacyl tRNA synthetase scientists at The Scripps Research Institute.